التفاصيل البيبلوغرافية
العنوان: |
Extracorporeal membrane oxygenation for COVID-19-related acute respiratory distress syndrome: a narrative review |
المؤلفون: |
Alessandri, Francesco, Di Nardo, Matteo, Ramanathan, Kollengode, Brodie, Daniel, MacLaren, Graeme |
سنة النشر: |
2023 |
المجموعة: |
Columbia University: Academic Commons |
مصطلحات موضوعية: |
Extracorporeal membrane oxygenation, COVID-19 (Disease), Respiratory distress syndrome, Respiratory insufficiency--Treatment, Respiratory organs--Diseases--Mortality |
الوصف: |
A growing body of evidence supports the use of extracorporeal membrane oxygenation (ECMO) for severe acute respiratory distress syndrome (ARDS) refractory to maximal medical therapy. ARDS may develop in a proportion of patients hospitalized for coronavirus disease 2019 (COVID-19) and ECMO may be used to manage patients refractory to maximal medical therapy to mitigate the risk of ventilator-induced lung injury and provide lung rest while awaiting recovery. The mortality of COVID-19-related ARDS was variously reassessed during the pandemic. Veno-venous (VV) ECMO was the default choice to manage refractory respiratory failure; however, with concomitant severe right ventricular dysfunction, venoarterial (VA) ECMO or mechanical right ventricular assist devices with extracorporeal gas exchange (Oxy-RVAD) were also considered. ECMO has also been used to manage special populations such as pregnant women, pediatric patients affected by severe forms of COVID-19, and, in cases with persistent and seemingly irreversible respiratory failure, as a bridge to successful lung transplantation. In this narrative review, we outline and summarize the most recent evidence that has emerged on ECMO use in different patient populations with COVID-19-related ARDS. |
نوع الوثيقة: |
article in journal/newspaper |
اللغة: |
English |
Relation: |
https://doi.org/10.7916/04xw-cr03 |
DOI: |
10.7916/04xw-cr03 |
الاتاحة: |
https://doi.org/10.7916/04xw-cr03 |
رقم الانضمام: |
edsbas.A1D77517 |
قاعدة البيانات: |
BASE |